|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.640 CNY | +1.15% |
|
0.00% | -18.01% |
| 05-19 | Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 04-24 | Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 3.88B 574M 500M 461M 434M 811M 54.11B 817M 5.49B 2.13B 26.66B 2.15B 2.11B 92.42B | P/E 2024 |
217x | P/E 2025 | 322x |
|---|---|---|---|---|---|
| Enterprise Value | 4.74B 701M 611M 563M 530M 991M 66.1B 998M 6.7B 2.6B 32.58B 2.63B 2.58B 113B | EV / Sales 2024 |
0.76x | EV / Sales 2025 | 0.77x |
| Free-Float |
66.17% | Yield 2024 |
0.37% | Yield 2025 | 0.06% |
| 1 day | +1.15% | ||
| Current month | -8.01% | ||
| 1 month | -12.58% | ||
| 3 months | -15.92% | ||
| 6 months | -24.79% | ||
| Current year | -18.01% |
| 1 week | 2.57 |  | 2.77 |
| 1 month | 2.57 | | 3.04 |
| Current year | 2.57 | | 4.11 |
| 1 year | 2.57 | | 4.69 |
| 3 years | 2.05 | | 4.69 |
| 5 years | 2.05 | | 6.73 |
| 10 years | 2.05 | | 18.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yun Feng
DFI | Director of Finance/CFO | 56 | 2021-04-25 |
Xu Han
PSD | President | 61 | 2023-05-25 |
Zhe Li
PRN | Corporate Officer/Principal | 40 | 2019-10-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Han
CHM | Chairman | 61 | 2009-11-20 |
Bo Yang
BRD | Director/Board Member | 43 | 2009-11-20 |
Li Yan Wu
CHM | Chairman | 48 | 2019-10-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-05-11 | Sell | Founder | 15,000,000 | 1.2902% | ||
| 23-03-29 | Sell | Founder | 13,040,000 | 1.1260% | ||
| 23-03-29 | Sell | Chairman | 2,000,000 | 0.1727% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | 0.00% | -8.65% | -23.26% | 568M | |
| -3.74% | -4.64% | +2.98% | +84.79% | 91.3B | |
| -1.99% | +0.28% | +34.08% | +143.04% | 53B | |
| -1.42% | +4.92% | -13.71% | +220.23% | 22.85B | |
| -1.24% | -2.03% | -9.60% | -26.78% | 8.05B | |
| +2.31% | -2.71% | -31.28% | -32.89% | 7.19B | |
| -2.73% | -2.50% | -10.78% | -36.88% | 6.71B | |
| -0.52% | -6.36% | +13.66% | +16.36% | 6.31B | |
| -1.54% | -1.89% | -3.26% | +15.82% | 5.3B | |
| +1.47% | +2.11% | -5.48% | -13.58% | 3.51B | |
| Average | -0.82% | -0.93% | -3.20% | +34.69% | 20.48B | |
| Weighted average by Cap. | -2.43% | +0.38% | +7.01% | +96.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.97B 1.18B 1.03B 947M 890M 1.67B 111B 1.68B 11.26B 4.37B 54.73B 4.42B 4.33B 190B | 7.3B 1.08B 940M 867M 815M 1.53B 102B 1.54B 10.31B 4.01B 50.13B 4.05B 3.96B 174B |
| Net income | 20.62M 3.05M 2.66M 2.45M 2.3M 4.31M 287M 4.34M 29.15M 11.32M 142M 11.45M 11.2M 491M | 16.07M 2.38M 2.07M 1.91M 1.8M 3.36M 224M 3.38M 22.72M 8.82M 110M 8.92M 8.73M 383M |
| Net Debt | 1.6B 236M 206M 190M 178M 334M 22.24B 336M 2.26B 876M 10.96B 886M 867M 37.99B | 860M 127M 111M 102M 96.14M 180M 11.99B 181M 1.22B 472M 5.91B 478M 467M 20.49B |
Employees
2,407
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 2.640 ¥ | +1.15% | 22,994,210 |
| 26-06-17 | 2.610 ¥ | -2.97% | 23,648,100 |
| 26-06-16 | 2.690 ¥ | -1.10% | 22,590,690 |
| 26-06-15 | 2.720 ¥ | +0.37% | 23,620,220 |
| 26-06-12 | 2.710 ¥ | +2.65% | 26,074,500 |
- Stock Market
- Stocks
- 002589 Stock
Select your edition
All financial news and data tailored to specific country editions
